Our founders have identified novel insights on how dysfunction of peripheral immune cells drives neurological disease. 

 

We have identified key checkpoints that restore healthy immune cell function and reduce injury to the CNS.

​

We are developing neuro-immunotherapies enabled by a PET tracer to image biomarkers of infiltration.

​

Our therapeutic approach offers personalized medicine for neurodegenerative diseases and other inflammatory conditions.